INIS
cancer
100%
ovaries
97%
patients
72%
tumors
38%
signals
29%
reviews
25%
carcinomas
24%
receptors
22%
comparative evaluations
20%
muscles
19%
lymph nodes
19%
estrogens
18%
risks
17%
diseases
16%
therapy
14%
tubes
13%
epithelium
13%
validation
12%
mapping
12%
management
12%
proteins
9%
malignancies
8%
phenotype
8%
netherlands
7%
assessments
7%
guidelines
7%
evaluation
6%
inclusions
6%
humans
6%
aggregation
6%
Keyphrases
Ovarian Cancer
43%
Pathway Activity
33%
Signal Transduction Pathway
32%
Meta-analysis
20%
Sentinel Lymph Node Mapping
19%
Sarcopenia
19%
Ovarian Cancer Patients
17%
Ovarian Carcinoma
17%
Tumor
13%
Systematic Meta-analysis
12%
Dutch
12%
Archipelago
12%
Cancer Research
12%
Skeletal muscle Index
12%
Clinical Benefit Rate
11%
Estrogen Receptor
11%
Recurrent Ovarian Cancer
9%
Sentinel Lymph Node
8%
Research Biobanks
8%
Functional Signals
8%
In Cancer
8%
Pathway Inhibitors
8%
Multicenter Cohort Study
8%
Simple Rules
8%
Endometrial Cancer
7%
Early-stage Ovarian Cancer
7%
Netherlands
7%
Overall Survival
7%
Therapy Response
7%
Biobank
7%
Medicine and Dentistry
Ovarian Cancer
65%
Signal Transduction Pathway
29%
Krukenberg Tumor
24%
Meta-Analysis
20%
Estrogen Receptor
19%
Sentinel Lymph Node
19%
Systematic Review
19%
Sarcopenia
19%
Skeletal Muscle
19%
Neoplasm
14%
Diseases
14%
Cancer Research
12%
Cancer
9%
Recurrent Ovarian Cancer
9%
Phosphoinositide 3-Kinase
8%
Ovarian Tumor
8%
Uterine Cancer
8%
Prospective Cohort Study
7%
Adnexal Mass
7%
Cohort Analysis
7%
Treatment Response
7%
Cervical Cancer
7%
Fallopian Tube Epithelium
7%
Overall Survival
6%
Fallopian Tube
6%
Precursor
6%
Cancer Surgery
6%
MAPK Signaling
6%
Cell Signaling Pathway
6%
PI3K/AKT/mTOR Pathway
6%